You just read:

Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

News provided by

Kyowa Kirin

08 Aug, 2018, 17:38 BST